NDC 59630-820

Cedax

Ceftibuten Dihydrate

Cedax is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Sciele Pharma, Inc.. The primary component is Ceftibuten Dihydrate.

Product ID59630-820_d1672f05-b1ee-40f9-9b4c-7ba2fad264fc
NDC59630-820
Product TypeHuman Prescription Drug
Proprietary NameCedax
Generic NameCeftibuten Dihydrate
Dosage FormCapsule
Route of AdministrationORAL
Marketing Start Date1995-12-20
Marketing CategoryNDA / NDA
Application NumberNDA050685
Labeler NameSciele Pharma, Inc.
Substance NameCEFTIBUTEN DIHYDRATE
Active Ingredient Strength400 mg/1
Pharm ClassesCephalosporin Antibacterial [EPC],Cephalosporins [CS]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 59630-820-20

20 CAPSULE in 1 BOTTLE (59630-820-20)
Marketing Start Date1995-12-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 59630-820-20 [59630082020]

Cedax CAPSULE
Marketing CategoryNDA
Application NumberNDA050685
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date1995-12-20
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
CEFTIBUTEN DIHYDRATE400 mg/1

OpenFDA Data

SPL SET ID:2dd58c88-142f-41ad-bc31-0a4fff074970
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 108395
  • 581580
  • 309086
  • 309087
  • Pharmacological Class

    • Cephalosporin Antibacterial [EPC]
    • Cephalosporins [CS]

    NDC Crossover Matching brand name "Cedax" or generic name "Ceftibuten Dihydrate"

    NDCBrand NameGeneric Name
    59630-820CedaxCeftibuten dihydrate
    59630-821CedaxCeftibuten dihydrate

    Trademark Results [Cedax]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CEDAX
    CEDAX
    73825904 1610363 Live/Registered
    LABORATOIRES UNICET
    1989-09-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.